Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas. GlobalData's Medical Devices sector report, “Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Artificial Pancreas report provides key information and data related to:
Extensive coverage of the Artificial Pancreas under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Artificial Pancreas pipeline products.
Review of Recent Developments in the segment / industry
The Artificial Pancreas report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Artificial Pancreas under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

– 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
– 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
– 64,000+ medical equipment company profiles
– 5,600+ company profiles of medical equipment manufacturers in China and India
– 2,200+ company profiles of medical equipment manufacturers in Japan
– 1,200+ companies’ revenue splits and market shares
– 1,600+ quarterly and annual medical equipment company financials
– 850+ medical equipment company SWOTs
– 28,000+ pipeline product profiles
– 56,400+ marketed product profiles
– 47,000+ clinical trials
– 41,500+ trial investigators
– 7,000+ reports on companies with products in development
– 44,000+ deals in the medical equipment industry
– 1,100+ surgical and diagnostic procedures by therapy area
– 50+ key healthcare indicators by country
– 431,000+ Themes Content Items
– 600+ Influencers
– 1,900+ Analysts & Researchers
– 0.5m+ Community Members
– 141,000+ Macroeconomic Indicators
– 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Artificial Pancreas Pipeline Market Segmentation by Territories

Some of the key territories in the artificial pancreas market are the US, Europe, China, Australia, Canada, Japan, and South Korea. As of November 2023, the US has the highest number of pipeline products.

Artificial Pancreas Pipeline Market Analysis by Territories, 2023 (%)

Artificial Pancreas Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the artificial pancreas pipeline market are PMA, CE, NMPA, 510(k), Shonin, and TGA among others. As of November 2023, PMA is the most followed pathway for pipeline products in the market.

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market – Competitive Landscape

Some of the key companies in the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, Beta Bionics Inc, and Bigfoot Biomedical Inc among others.

Admetsys Corp (Admetsys): Admetsys Corp (Admetsys) provides artificial pancreas devices for surgical care and hospitals to counterbalance the treatment of glucose and insulin. It offers its solutions for physicians, nurses, and administrators.

Artificial Pancreas Pipeline Market Analysis by Companies, 2023

Artificial Pancreas Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Artificial Pancreas Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • Canada
  • Japan
  • South Korea

Artificial Pancreas Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • 510(k)
  • Shonin
  • TGA

Scope

– Extensive coverage of the Artificial Pancreas under development _x000D_

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities_x000D_

– The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects_x000D_

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage_x000D_

– The report provides key clinical trial data of ongoing trials specific to pipeline products_x000D_

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to – _x000D_

– Formulate significant competitor information, analysis, and insights to improve R&D strategies_x000D_

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage_x000D_

– Identify and understand important and diverse types of Artificial Pancreas under development_x000D_

– Develop market-entry and market expansion strategies_x000D_

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline_x000D_

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Admetsys Corp
Advanced Biosensors-Ohio LLC
AiTA Bio Inc
Beta Bionics Inc
Beta-O2 Technologies Ltd
Bigfoot Biomedical Inc
BioTex Inc
Captix Biomedical Pty Ltd
Cerco Medical LLC
Children's Hospital of Philadelphia
Converge Biotech
Inc.
Covalor Medical
LLC
De Montfort University
Debiotech SA
Defymed SAS
Diabeloop SA
EOFlow Co Ltd
Giner Inc
Harvard John A Paulson School of Engineering and Applied Sciences
Healios Inc
Humacyte Inc
Ideal Medical Technologies Inc
Imperial College London
Indian Institute of Science
Inreda Diabetic BV
Joslin Diabetes Center
Kailian Medical Technology Co Ltd
Kencak LLC
McGill University
Medtronic Inc
Medtronic MiniMed Inc
MicroTech Medical Co Ltd
Miromatrix Medical Inc
Modular Medical Inc
Pacific Diabetes Technologies Inc
Pancreum
LLC
PharmaCyte Biotech Inc
Polytechnic University of Valencia
Rensselaer Polytechnic Institute
Senseonics Holdings Inc
Shenzhen Huayuan Regenerative Medicine Co Ltd
Stanford University
TecMed Inc
TypeZero Technologies LLC
U-Needle BV
Universidad Autonoma de Madrid
University of California San Francisco
University of California Santa Barbara
University of Cambridge
University of Florida
University of Minnesota
University of Newcastle
University of Pennsylvania
University of Queensland
WaveForm Technologies Inc
Xeris Biopharma Holdings Inc
Yale University
Ypsomed Holding AG

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 10

2 Introduction 11

2.1 Artificial Pancreas Overview 11

3 Products under Development 12

3.1 Artificial Pancreas – Pipeline Products by Stage of Development 12

3.2 Artificial Pancreas – Pipeline Products by Territory 13

3.3 Artificial Pancreas – Pipeline Products by Regulatory Path 14

3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

3.5 Artificial Pancreas – Ongoing Clinical Trials 16

4 Artificial Pancreas – Pipeline Products under Development by Companies 17

4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development 17

4.2 Artificial Pancreas – Pipeline Products by Stage of Development 20

5 Artificial Pancreas Companies and Product Overview 22

5.1 Admetsys Corp Company Overview 22

5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Advanced Biosensors-Ohio LLC Company Overview 24

5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 AiTA Bio Inc Company Overview 25

5.3.1 AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Beta Bionics Inc Company Overview 26

5.4.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Beta-O2 Technologies Ltd Company Overview 29

5.5.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Bigfoot Biomedical Inc Company Overview 30

5.6.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 BioTex Inc Company Overview 31

5.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Captix Biomedical Pty Ltd Company Overview 32

5.8.1 Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Cerco Medical LLC Company Overview 33

5.9.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Children's Hospital of Philadelphia Company Overview 34

5.10.1 Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Converge Biotech, Inc. Company Overview 35

5.11.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Covalor Medical, LLC Company Overview 36

5.12.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 De Montfort University Company Overview 37

5.13.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Debiotech SA Company Overview 38

5.14.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Defymed SAS Company Overview 39

5.15.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Diabeloop SA Company Overview 40

5.16.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 EOFlow Co Ltd Company Overview 41

5.17.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 Giner Inc Company Overview 42

5.18.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview 43

5.19.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 Healios Inc Company Overview 44

5.20.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 Humacyte Inc Company Overview 45

5.21.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 Ideal Medical Technologies Inc Company Overview 46

5.22.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Imperial College London Company Overview 49

5.23.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 Indian Institute of Science Company Overview 50

5.24.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 Inreda Diabetic BV Company Overview 51

5.25.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 51

5.26 Joslin Diabetes Center Company Overview 52

5.26.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 52

5.27 Kailian Medical Technology Co Ltd Company Overview 53

5.27.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

5.28 Kencak LLC Company Overview 55

5.28.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 55

5.29 McGill University Company Overview 56

5.29.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 56

5.30 Medtronic Inc Company Overview 57

5.30.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.31 Medtronic MiniMed Inc Company Overview 59

5.31.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.32 MicroTech Medical Co Ltd Company Overview 60

5.32.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.33 Miromatrix Medical Inc Company Overview 63

5.33.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.34 Modular Medical Inc Company Overview 64

5.34.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.35 Pacific Diabetes Technologies Inc Company Overview 65

5.35.1 Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.36 Pancreum, LLC Company Overview 68

5.36.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

5.37 PharmaCyte Biotech Inc Company Overview 69

5.37.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.38 Polytechnic University of Valencia Company Overview 70

5.38.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 70

5.39 Rensselaer Polytechnic Institute Company Overview 71

5.39.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 71

5.40 Senseonics Holdings Inc Company Overview 72

5.40.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.41 Shenzhen Huayuan Regenerative Medicine Co Ltd Company Overview 73

5.41.1 Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.42 Stanford University Company Overview 74

5.42.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 74

5.43 TecMed Inc Company Overview 75

5.43.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.44 TypeZero Technologies LLC Company Overview 76

5.44.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.45 U-Needle BV Company Overview 79

5.45.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 79

5.46 Universidad Autonoma de Madrid Company Overview 80

5.46.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 80

5.47 University of California San Francisco Company Overview 81

5.47.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 81

5.48 University of California Santa Barbara Company Overview 82

5.48.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 82

5.49 University of Cambridge Company Overview 84

5.49.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 84

5.50 University of Florida Company Overview 87

5.50.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 87

5.51 University of Minnesota Company Overview 88

5.51.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 88

5.52 University of Newcastle Company Overview 89

5.52.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 89

5.53 University of Pennsylvania Company Overview 90

5.53.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 90

5.54 University of Queensland Company Overview 91

5.54.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 91

5.55 WaveForm Technologies Inc Company Overview 92

5.55.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.56 Xeris Biopharma Holdings Inc Company Overview 93

5.56.1 Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.57 Yale University Company Overview 94

5.57.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 94

5.58 Ypsomed Holding AG Company Overview 95

5.58.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 95

6 Artificial Pancreas – Recent Developments 99

6.1 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference 99

6.2 Nov 14, 2023: Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies 99

6.3 Nov 14, 2023: Miromatrix Reports Third Quarter 2023 Results 99

6.4 Oct 12, 2023: Mylife Loop Improves Health of Pregnant Women With Type 1 Diabetes and Their Babies 100

6.5 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President 101

6.6 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 102

6.7 Oct 03, 2023: Insulet Announces CFO Transition 102

6.8 Sep 06, 2023: Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital 103

6.9 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 103

6.10 Aug 14, 2023: Miromatrix Medical Reports Second Quarter 2023 Results and Provides Corporate Update 104

6.11 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 104

6.12 Jul 07, 2023: Beta Bionics Receives an Additional 510(k) Clearance for iLet Bionic Pancreas System 105

6.13 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023 105

6.14 May 22, 2023: Beta Bionics wins FDA approval for new insulin pump 105

6.15 May 22, 2023: Beta Bionics announces FDA clearance and commercialization of the iLet Bionic Pancreas 106

6.16 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 107

6.17 Apr 27, 2023: Humacyte, JDRF collaborating to develop insulin-producing Biovascular Pancreas to treat Type 1 Diabetes 107

6.18 Apr 12, 2023: Medtronic has a layoff in California 108

6.19 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 108

6.20 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions 108

6.21 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year 108

7 Appendix 112

7.1 Methodology 112

7.2 About GlobalData 115

7.3 Contact Us 115

7.4 Disclaimer 115

Table

Artificial Pancreas – Pipeline Products by Stage of Development 12

Artificial Pancreas – Pipeline Products by Territory 13

Artificial Pancreas – Pipeline Products by Regulatory Path 14

Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

Artificial Pancreas – Ongoing Clinical Trials 16

Artificial Pancreas Companies – Pipeline Products by Stage of Development 17

Artificial Pancreas – Pipeline Products by Stage of Development 20

Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Smart Pancreas – Product Status 22

Smart Pancreas – Product Description 23

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Artificial Pancreas – Product Status 24

Artificial Pancreas – Product Description 24

AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Next-Generation Artificial Pancreas – Product Status 25

Next-Generation Artificial Pancreas – Product Description 25

Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Gen 2 GlucoSTAT – Product Status 26

Gen 2 GlucoSTAT – Product Description 26

Gen 4 iLet System – Product Status 27

Gen 4 iLet System – Product Description 27

iLet Bionic Pancreas – Glucagon-only – Product Status 27

iLet Bionic Pancreas – Glucagon-only – Product Description 28

Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

ßAir Bio-artificial Pancreas – Product Status 29

ßAir Bio-artificial Pancreas – Product Description 29

Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Bigfoot Autonomy – Product Status 30

Bigfoot Autonomy – Product Description 30

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Artificial Pancreas – Product Status 31

Artificial Pancreas – Product Description 31

Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

IMITA Device – Product Status 32

IMITA Device – Product Description 32

Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 33

Bioartificial Pancreas – Product Status 33

Bioartificial Pancreas – Product Description 33

Children's Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 34

Bihormonal Bionic Pancreas – Product Status 34

Bihormonal Bionic Pancreas – Product Description 34

Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

Bioartificial Pancreas System – Product Status 35

Bioartificial Pancreas System – Product Description 35

Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 36

Artificial Pancreas – Product Status 36

Artificial Pancreas – Product Description 36

De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 37

InSmart Artificial Pancreas – Product Status 37

InSmart Artificial Pancreas – Product Description 37

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 38

Next Generation Artificial Pancreas – Product Status 38

Next Generation Artificial Pancreas – Product Description 38

Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 39

MAILPAN – Product Status 39

MAILPAN – Product Description 39

Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 40

DBLG1 – Pediatric Version – Product Status 40

DBLG1 – Pediatric Version – Product Description 40

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

EOPatchX – Product Status 41

EOPatchX – Product Description 41

Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 42

BAPIOS System – Product Status 42

BAPIOS System – Product Description 42

Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 43

Pregnancy-Specific Artificial Pancreas – Product Status 43

Pregnancy-Specific Artificial Pancreas – Product Description 43

Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Bioengineered Pancreas – Product Status 44

Bioengineered Pancreas – Product Description 44

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 45

BioVascular Pancreas – Product Status 45

BioVascular Pancreas – Product Description 45

Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Fusion System – Product Status 46

Fusion System – Product Description 46

Ideal Medical Technologies Inc – Ongoing Clinical Trials Overview 47

Fusion System – Demonstration of an Artificial Intelligence Based Closed Loop Glucose Control System as a Therapeutic Modality in Type 1 and Type 2 Diabetic Patients 48

Fusion System – Prospective Randomized Controlled Trial For Use of the FUSION Artificial Pancreas System as a Therapy for COVID-19 48

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 49

Bio-inspired Artificial Pancreas – Product Status 49

Bio-inspired Artificial Pancreas – Product Description 49

Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 50

Artificial Pancreas System – Product Status 50

Artificial Pancreas System – Product Description 50

Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 51

Bi-Hormonal Artificial Pancreas – Lighter Version – Product Status 51

Bi-Hormonal Artificial Pancreas – Lighter Version – Product Description 51

Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 52

Closed-Loop Glucagon Delivery System – Product Status 52

Closed-Loop Glucagon Delivery System – Product Description 52

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

Artificial Pancreas System – Product Status 53

Artificial Pancreas System – Product Description 53

Semi-Closed-Loop Blood Glucose Management Device – Product Status 54

Semi-Closed-Loop Blood Glucose Management Device – Product Description 54

Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 55

BioArtificial Pancreas – Product Status 55

BioArtificial Pancreas – Product Description 55

McGill University Pipeline Products & Ongoing Clinical Trials Overview 56

Artificial Pancreas – Type 1 Diabetes – Product Status 56

Artificial Pancreas – Type 1 Diabetes – Product Description 56

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Implantable Artificial Pancreas Device – Product Status 57

Implantable Artificial Pancreas Device – Product Description 57

Third-Generation Artificial Pancreas System – Product Status 58

Third-Generation Artificial Pancreas System – Product Description 58

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Minimed 890G – Product Status 59

Minimed 890G – Product Description 59

MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Cloud-Based AI-Powered Artificial Pancreas – Product Status 60

Cloud-Based AI-Powered Artificial Pancreas – Product Description 60

PanCares – Artificial Pancreas – Product Status 61

PanCares – Artificial Pancreas – Product Description 61

PanCares – Children And Adolescents – Product Status 61

PanCares – Children And Adolescents – Product Description 62

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Miro Pancreas – Product Status 63

Miro Pancreas – Product Description 63

Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 64

MODD2 – Product Status 64

MODD2 – Product Description 64

Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

SynerG – Product Status 65

SynerG – Product Description 65

Pacific Diabetes Technologies Inc – Ongoing Clinical Trials Overview 66

SynerG – A 48hr Study to Test Feasibility of the Pacific Diabetes Technologies Continuous Glucose Monitor Infusion Set (CGMIS) Sensing Interstitial Glucose Continuously in the Immediate Vicinity of SQ Insulin Delivery in Adults With T1 Diabetes 67

SynerG – Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes 67

Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Genesis Artificial Pancreas – Product Status 68

Genesis Artificial Pancreas – Product Description 68

PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Bio-Artificial Pancreas – Product Status 69

Bio-Artificial Pancreas – Product Description 69

Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 70

ClosedLoop 4Meal – Product Status 70

ClosedLoop 4Meal – Product Description 70

Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 71

Closed-Loop Artificial Pancreas System – Product Status 71

Closed-Loop Artificial Pancreas System – Product Description 71

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Status 72

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Description 72

Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

Bioartificial Pancreas – Type I Diabetes – Product Status 73

Bioartificial Pancreas – Type I Diabetes – Product Description 73

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 74

Artificial Pancreas Device – Product Status 74

Artificial Pancreas Device – Product Description 74

TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Artificial Pancreas – Product Status 75

Artificial Pancreas – Product Description 75

TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 76

inControl – Product Status 76

inControl – Product Description 76

TypeZero Technologies LLC – Ongoing Clinical Trials Overview 77

inControl – Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump 78

U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 79

Microneedle Artificial Pancreas – Product Status 79

Microneedle Artificial Pancreas – Product Description 79

Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 80

Predictive Rule-Based Algorithm – Product Status 80

Predictive Rule-Based Algorithm – Product Description 80

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 81

Implantable Bioartificial Pancreas – Product Status 81

Implantable Bioartificial Pancreas – Product Description 81

University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 82

Closed-Loop Artificial Pancreas – Product Status 82

Closed-Loop Artificial Pancreas – Product Description 82

Pediatric Artificial Pancreas – Product Status 83

Pediatric Artificial Pancreas – Product Description 83

University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 84

Artificial Pancreas – Type 2 Diabetes – Product Status 84

Artificial Pancreas – Type 2 Diabetes – Product Description 84

Florence D2A System – Product Status 85

Florence D2A System – Product Description 85

FlorenceM – Product Status 85

FlorenceM – Product Description 86

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 87

Bioartificial Pancreas – Type 1 Diabetes – Product Status 87

Bioartificial Pancreas – Type 1 Diabetes – Product Description 87

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 88

Implantable Microvalve Device – Product Status 88

Implantable Microvalve Device – Product Description 88

University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 89

Closed Glucose-Sensing Insulin-Delivery System – Product Status 89

Closed Glucose-Sensing Insulin-Delivery System – Product Description 89

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 90

Artificial Pancreas Algorithm – Product Status 90

Artificial Pancreas Algorithm – Product Description 90

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 91

Bionic Artificial Pancreas – Product Status 91

Bionic Artificial Pancreas – Product Description 91

WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 92

Closed Loop Insulin Delivery Solution – Product Status 92

Closed Loop Insulin Delivery Solution – Product Description 92

Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Bi-Hormonal Artificial Pancreas – Product Status 93

Bi-Hormonal Artificial Pancreas – Product Description 93

Yale University Pipeline Products & Ongoing Clinical Trials Overview 94

Automated Insulin Delivery System – Product Status 94

Automated Insulin Delivery System – Product Description 94

Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 95

mylife Loop – Product Status 95

mylife Loop – Product Description 96

Ypsomed Holding AG – Ongoing Clinical Trials Overview 97

mylife Loop – Randomised Open Label Clinical Trial Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) With Advanced Bolus-Free Features in Adults With Type 1 Diabetes: Extension Trial Using Ultra-Fast Acting Insulin 98

mylife Loop – Randomized Open Label Clinical Trial Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with Advanced Bolus-free Features in Adults with Type 1 Diabetes 98

Glossary 114

Figures

Artificial Pancreas – Pipeline Products by Stage of Development 12

Artificial Pancreas – Pipeline Products by Territory 13

Artificial Pancreas – Pipeline Products by Regulatory Path 14

Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

Artificial Pancreas – Ongoing Clinical Trials 16

Frequently asked questions

Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.